Predicting ROS1 Fusions and Targetable Mutations in Non-small Cell Lung Cancer through H-score Pathological Analysis

被引：0
|
作者：
Soussi, G. [1 ,2 ]
Hercent, A. [3 ]
Gounant, V. [1 ,2 ]
Lupo, A. [4 ]
Cazes, A. [5 ]
Lamoril, J. [3 ]
Guyard, A. [5 ]
Theou-Anton, N. [3 ]
机构：
[1] Univ Paris Cite, Thorac Oncol Dept, Paris, France
[2] Nord Univ Paris Cite, Bichat Claude Bernard Univ Hosp, Canc Inst AP HP, CIC1425 CLIP2 Early Phase Canc Clin Trials Unit, Paris, France
[3] Univ Paris Cite, Canc Inst APHP Nord, Bichat Claude Bernard Univ Hosp, Dept Genet, Paris, France
[4] Univ Paris Cite, Cochin Univ Hosp, Dept Pathol, Paris, France
[5] Nord Univ Paris Cite, Bichat Claude Bernard Univ Hosp, Canc Inst AP HP, Dept Pathol, Paris, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer; ROS1; fusions; Immunohistochemistry;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.03-15
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [31] MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1
    Chunhua Yan
    Wei Zhang
    Xiaodong Shi
    Jiaolin Zheng
    Xiaoming Jin
    Jianmin Huo
    Environmental Science and Pollution Research, 2018, 25 : 18385 - 18391
  • [32] Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer
    Cheung, Carol C.
    Smith, Adam C.
    Albadine, Roula
    Bigras, Gilbert
    Bojarski, Anna
    Couture, Christian
    Cutz, Jean-Claude
    Huang, Weei-Yuan
    Ionescu, Diana
    Itani, Doha
    Izevbaye, Iyare
    Karsan, Aly
    Kelly, Margaret M.
    Knoll, Joan
    Kwan, Keith
    Nasr, Michel R.
    Qing, Gefei
    Rashid-Kolvear, Fariboz
    Sekhon, Harmanjatinder S.
    Spatz, Alan
    Stockley, Tracy
    Danh Tran-Thanh
    Tucker, Tracy
    Waghray, Ranjit
    Wang, Hangjun
    Xu, Zhaolin
    Yatabe, Yasushi
    Torlakovic, Emina E.
    Tsao, Ming-Sound
    LUNG CANCER, 2021, 160 : 127 - 135
  • [33] Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
    Kim, Young-gon
    Lee, Boram
    Ha, Changhee
    Lee, Cheonghwa
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Myung-Ju
    Choi, Yoon-La
    Park, Sehhoon
    Kim, Jong-Won
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [34] Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma: the ROSING Study
    Conde, Esther
    Hernandez, Susana
    Martinez, Rebeca
    Angulo, Barbara
    De Castro, Javier
    Collazo-Lorduy, Ana
    Jimenez, Beatriz
    Muriel, Alfonso
    Luis Mate, Jose
    Moran, Teresa
    Aranda, Ignacio
    Massuti, Bartomeu
    Rojo, Federico
    Domine, Manuel
    Sansano, Irene
    Garcia, Felip
    Felip, Enriqueta
    Mancheno, Nuria
    Juan, Oscar
    Sanz, Julian
    Luis Gonzalez-Larriba, Jose
    Atienza-Cuevas, Lidia
    Arriola-Arellano, Esperanza
    Abdulkader, Ihab
    Garcia-Gonzalez, Jorge
    Camacho, Carmen
    Rodriguez-Abreu, Delvys
    Teixido, Cristina
    Reguart, Noemi
    Gonzalez-Pineiro, Ana
    Lazaro-Quintela, Martin
    Dolores Lozano, Maria
    Gurpide, Alfonso
    Gomez-Roman, Javier
    Lopez-Brea, Marta
    Pijuan, Lara
    Salido, Marta
    Arriola, Edurne
    Company, Amparo
    Insa, Amelia
    Esteban-Rodriguez, Isabel
    Saiz, Monica
    Azkona, Eider
    Alvarez, Ramiro
    Artal, Angel
    Plaza, Maria Luz
    Aguiar, David
    Belen Enguita, Ana
    Benito, Amparo
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2120 - 2132
  • [35] Detecting ALK, ROS1 and RET Gene Translocations in Non-Small Cell Lung Cancer (NSCLC) with the NanoString Platform
    Wang, H.
    Rijk, A.
    Aguirre, M.
    Wang, A.
    Wang, K.
    Dastani, Z.
    Agulnik, J.
    Cohen, V.
    Small, D.
    Pepe, C.
    Sakr, L.
    Kasymjanova, G.
    Van Kempen, L.
    Spatz, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2257 - S2257
  • [36] Crizotinib for ROS1-rearranged non-small cell lung cancer patients
    Domblides, Charlotte
    Antoine, Martine
    Lavole, Armelle
    Cadranel, Jacques
    Wislez, Marie
    BULLETIN DU CANCER, 2017, 104 (04) : 303 - 310
  • [37] ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases
    Warth, Arne
    Muley, Thomas
    Dienemann, Hendrik
    Goeppert, Benjamin
    Stenzinger, Albrecht
    Schnabel, Philipp A.
    Schirmacher, Peter
    Penzel, Roland
    Weichert, Wilko
    HISTOPATHOLOGY, 2014, 65 (02) : 187 - 194
  • [38] ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
    Gendarme, Sebastien
    Bylicki, Olivier
    Chouaid, Christos
    Guisier, Florian
    CURRENT ONCOLOGY, 2022, 29 (02) : 641 - 658
  • [39] Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer
    Li, Ziming
    Shen, Lan
    Ding, Ding
    Huang, Jia
    Zhang, Jie
    Chen, Zhiwei
    Lu, Shun
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : 987 - 995
  • [40] Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Arrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S494 - S494
12345